Related Topics News -

     
 Detail   |   Print 
     
《大行》摩通:第11批國家藥品集中採購透明度更高 料對製藥公司影響逐漸減弱
2025-07-17T  
《大行》高盛:中國生物醫藥產品出海授權趨勢屬結構性 升中生目標價至6.19元
2025-07-09T  
恆指曾回吐逾300點 小米跌4% 獲大行唱好九置逆升6% 半新股周六福椰子水IFBH各挫約一成
2025-07-03T  
《回顧》恆指2025年上半年五大最強及最弱股份(表)
2025-06-30T  
《大行》交銀國際:港股處方藥板塊核心經營業務估值仍吸引 重點推薦先聲藥業
2025-06-23T  
《港股》恆指高開53點 阿里及騰訊造好 舜宇受捧
2025-06-20T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.